January 7, 2015
Cleveland HeartLab Acquires MIRISK Cardiovascular Disease Assessment Tool Technology
Cleveland HeartLab has acquired MIRISK, a cardiovascular disease assessment tool developed at Stanford University that can determine whether a patient is at risk for a heart attack.
Read More >